Skip to main content
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
5.49
+0.26 (4.97%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Foghorn Therapeutics Revenue

In the year 2023, Foghorn Therapeutics had annual revenue of $34.16M with 77.63% growth. Revenue in the quarter ending December 31, 2023 was $5.77M with 37.88% year-over-year growth.

Revenue (ttm)
$34.16M
Revenue Growth
+77.63%
P/S Ratio
6.84
Revenue / Employee
$294,440
Employees
116
Market Cap
233.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 324.01M
Coherus BioSciences 257.24M
Utah Medical Products 50.22M
AC Immune 17.62M
Adlai Nortye 5.00M
Revenue Rankings

FHTX News

More News